Federica Cavallo

Federica Cavallo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Federica Cavallo sits on this spectrum.

Federica Cavallo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Federica Cavallo sits on this spectrum.

Best Publications

• A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

  Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

  1673
  Citations

• Classification of current anticancer immunotherapies

  Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  584
  Citations

• Vaccines for tumour prevention

  Pier-Luigi Lollini;Federica Cavallo;Patrizia Nanni;Guido Forni

  416
  Citations

• Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

  Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  394
  Citations

• 2011: the immune hallmarks of cancer

  Federica Cavallo;Carla De Giovanni;Patrizia Nanni;Guido Forni

  393
  Citations

• Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

  Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  297
  Citations

• Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

  Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  254
  Citations

• Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

  Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

  250
  Citations

• Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

  M Giovarelli;P Musiani;A Modesti;P Dellabona

  250
  Citations

• The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy.

  Vincenzo Salemme;Giorgia Centonze;Federica Cavallo;Paola Defilippi

  231
  Citations

• CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

  Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

  223
  Citations

• Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

  Federica Cavallo;Paola Signorelli;Mirella Giovarelli;Piero Musiani

  204
  Citations

• Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

  Elena Quaglino;Manuela Iezzi;Cristina Mastini;Augusto Amici

  198
  Citations

• IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk.

  Marina Strasly;Federica Cavallo;Massimo Geuna;Stefania Mitola

  188
  Citations

• Immune Events Associated with the Cure of Established Tumors and Spontaneous Metastases by Local and Systemic Interleukin 12

  Federica Cavallo;Emma Di Carlo;Monia Butera;Roberta Verrua

  185
  Citations

• p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis

  Sara Cabodi;Agata Tinnirello;Paola Di Stefano;Brigitte Bisarò

  167
  Citations

• Consensus nomenclature for CD8+ T cell phenotypes in cancer

  Lionel Apetoh;Mark J. Smyth;Charles G. Drake;Jean Pierre Abastado

  162
  Citations

• An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

  F Pericle;M Giovarelli;M P Colombo;G Ferrari

  154
  Citations

• Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

  Federica Cavallo;Alfonso Martin-Fontecha;Matteo Bellone;Silvia Heltai

  153
  Citations

• Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer

  Paola Cappello;Simona Rolla;Roberto Chiarle;Moitza Principe

  153
  Citations